Prospera Financial Services’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-2,993
| Closed | -$351K | – | 1670 |
|
|
2022
Q1 | $351K | Buy |
2,993
+1,030
| +52% | +$121K | 0.01% | 702 |
|
|
2021
Q4 | $264K | Sell |
1,963
-856
| -30% | -$115K | 0.01% | 743 |
|
|
2021
Q3 | $449K | Buy |
2,819
+452
| +19% | +$72K | 0.02% | 563 |
|
|
2021
Q2 | $311K | Buy |
2,367
+85
| +4% | +$11.2K | 0.02% | 644 |
|
|
2021
Q1 | $294K | Buy |
2,282
+378
| +20% | +$48.7K | 0.02% | 623 |
|
|
2020
Q4 | $318K | Sell |
1,904
-599
| -24% | -$100K | 0.02% | 524 |
|
|
2020
Q3 | $386K | Sell |
2,503
-87
| -3% | -$13.4K | 0.15% | 126 |
|
|
2020
Q2 | $383K | Sell |
2,590
-165
| -6% | -$24.4K | 0.03% | 395 |
|
|
2020
Q1 | $310K | Sell |
2,755
-527
| -16% | -$59.3K | 0.03% | 385 |
|
|
2019
Q4 | $457K | Buy |
+3,282
| New | +$457K | 0.04% | 396 |
|